IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Russia’s largest pharmaceutical company to buy Singapore-based API supplier for $590 million

12:31 AM MDT | August 19, 2013 | Deepti Ramesh

Pharmstandard (Moscow), Russia’s leading pharmaceutical company, says it will acquire Bever Pharmaceutical (Singapore), a supplier of active pharmaceutical ingredients (APIs), for a total of $590 million. Russian businessman Alexander Shuster, a non-executive board member of Pharmstandard, currently owns 100% stake in Bever. Following the completion of the transaction, Shuster will become the second largest shareholder of Pharmstandard with a stake of about 18.74%. The strategic rationale for the proposed acquisition includes securing a long-term supply of...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa